Secukinumab for NLD (Cosentyx) in Patients With Necrobiosis Lipoidica Diabeticorum (NLD)
Clinical trial NCT03791060 · TERMINATED
Trial details
- NCT number
- NCT03791060
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-03
- Primary completion
- 2021-01-17
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.